The Team
Glen
Travers – Co-Chairman:
Glen co-founded Proxima in 2000 and serves
as its Chairman. Glen has 25 years of experience
in building and managing healthcare companies,
successfully taking several diagnostic and
therapeutic products through development to
the market, some of which were developed in
collaboration with multinational pharmaceutical
partners. In addition, Glen is experienced
in international fundraising, has been a Board
member of various public and international
Boards and served as Executive Chairman of
Cortecs Ltd., a company listed on both the
London Stock Exchange and NASDAQ.
Dr. Roger New
– Chief Scientific Officer:
Roger co-founded Proxima in 2000 and serves
as its Chief Scientist. Roger is a distinguished
scientist with a background in biochemistry
and immunology. During his 30 years of experience
in drug delivery, he has invented three novel
systems for the oral delivery of insulin,
gaining the first positive human results ever
observed in patients with type 1 diabetes.
Previously, Roger served as Head of Research
at Cortecs Ltd. and as a senior research scientist
at Biocompatibles Ltd. He is the author of
many patents in areas of pharmaceutics, diagnostics
and microbiology, a world-recognised expert
in liposomes and author of a seminal reference
book.
Timothy Earle
– Chief Operating Officer:
Timothy joined Proxima in January 2005 responsible
for overseeing the corporate and business
development activities of Diabetology. Timothy
has 20 years of experience in the biotechnology
industry with a venture capital company, as
a strategic consultant, CFO and business development
director. Previously, Timothy served as Business
Development Director at Biorex Research and
Development Company, a European pharmaceutical
research venture, and Group Finance Director
of its UK holding company, BRX Research and
Development Co. Ltd. Prior to this, Timothy
worked in the business strategy practice at
PA Consulting Group and as Director of Finance
for VimRx Pharmaceuticals in the United States.
Dr. Anthony
Lockett – Medical
Director: Anthony has served as an
advisor and part-time Medical Director to
Proxima since 2005. Anthony is a Medical Doctor
and microbiologist with 20 years of experience
in medicine and clinical drug development,
with a focus on endocrinology and immunology.
He has been actively involved in planning
and overseeing over 50 clinical trials and
has acted as the Medical Director of 14 clinical
trials in diabetes and obesity. Anthony has
previously worked for the UK Department of
Health and been Senior Medical Adviser at
Covance. Anthony is a leader of the special
interest group in risk management for the
International Society of Pharmacoeconomics
and Outcomes Research and a frequent speaker
and author on the subject of risk management
in clinical research.
Timothy
Broke-Smith - Corporate Development
Officer: Timothy is a graduate of
Bioscience Enterprise at Cambridge University
and Biology at Imperial College London, with
experience in cellular and molecular biology
research and corporate analysis.
|
